Market Place
Sourcing Support
Cellectar & NorthStar Partner for Actinium-225 Supply
14 Nov 2024 //
GLOBENEWSWIRE
NorthStar Unveils CDMO Facility For Radiopharmaceuticals
22 Oct 2024 //
BUSINESSWIRE
NorthStar Medical To Present At October Oppenheimer Conference
03 Oct 2024 //
BUSINESSWIRE
NorthStar And Convergent Expand Collaboration On CONV01-?
13 Aug 2024 //
BUSINESSWIRE
NorthStar Medical Sponsors ANCA-Associated Vasculitis Research
30 Jul 2024 //
BUSINESSWIRE
BWXT And NorthStar Sign Supply Deal For Actinium-225 Production
22 Jul 2024 //
BUSINESSWIRE
NorthStar: Clinical Batch Production Readiness Milestone
04 Jun 2024 //
BUSINESSWIRE
NorthStar Appoints Peter Pfreundschuh To Board
15 Apr 2024 //
BUSINESSWIRE
NorthStar Medical Radioisotopes Enters Clinical Supply Pact
10 Apr 2024 //
CONTRACTPHARMA
NorthStar Medical Radioisotopes Supports Clarity Cu-67 SAR-bisPSMA Trials
10 Apr 2024 //
BUSINESSWIRE
NorthStar Announces Participation in Jefferies Radiopharma Innovation Summit
04 Apr 2024 //
BUSINESSWIRE
NorthStar Appointed Barbara Bodem & David Keeling to Board of Managers
27 Feb 2024 //
BUSINESSWIRE
NorthStar Medical Radioisotopes and Alpha-9 Oncology Enter Strategic Agreement
08 Jan 2024 //
BUSINESSWIRE
NorthStar Medical Radioisotopes and Curadh MTR Enter Strategic Collaboration
03 Jan 2024 //
BUSINESSWIRE
NorthStar Announces Participation in 2023 Truist Securities Biopharma Symposium
06 Nov 2023 //
BUSINESSWIRE
NorthStar Medical Radioisotopes and Curadh MTR a Strategic Supply Agreement
29 Aug 2023 //
BUSINESSWIRE
First Participant Treated Using NorthStar Med Radioisotopes’ (Cu-67)
28 Aug 2023 //
BUSINESSWIRE
NorthStar Medical Radioisotopes Executes Supply Agreement with Bayer for Ac-225
18 Jul 2023 //
BUSINESSWIRE
Northstar Medical Radioisotopes, Nucleus Radiopharma Ink Supply Pact
27 Jun 2023 //
CONTRACT PHARMA
NorthStar Medical Routinely Manufacturing High Activity Copper-67
26 Jun 2023 //
BUSINESSWIRE
Radioisotope manufacturer NorthStar Medical Technologies names new CEO
22 Jun 2023 //
ENDPTS
NorthStar Medical Radioisotopes Announces Participation in Upcoming 2023
09 May 2023 //
BUSINESSWIRE
NorthStar Medical Radioisotopes Expands Management Team with Appointment
18 Apr 2023 //
BUSINESSWIRE
NorthStar Medical Announces Promotion of Jason Vinyard to Vice President
12 Apr 2023 //
BUSINESSWIRE
NorthStar Medical Provides Updates on Corporate Progress and Upcoming Milestones
03 Apr 2023 //
BUSINESSWIRE
NorthStar Announces Presentations at Jefferies Radiopharma Innovation Summit
30 Mar 2023 //
BUSINESSWIRE
NorthStar Medical Receives Electron Beam Accelerator for First-of-its-Kind
01 Mar 2023 //
BUSINESSWIRE
NorthStar Radioisotopes Hosting Expansion Event on Wednesday, February 22
15 Feb 2023 //
BUSINESSWIRE
NorthStar Sets New Industry Precedent in Advancing Production of Molybdenum-99
11 Jan 2023 //
BUSINESSWIRE
NorthStar Medical Radioisotopes and Inhibrx Enter Collaboration
05 Jan 2023 //
CONTRACT PHARMA
NorthStar Medical Radioisotopes Expands Its Business Platform
17 Nov 2022 //
CONTRACTPHARMA
NorthStar Medical Expands Business Platform with Radiopharmaceutical CDMO Unit
15 Nov 2022 //
BUSINESSWIRE
NorthStar Medical Radioisotopes & IBA Sign Agreement for 2 Additional Rhodotron®
19 Sep 2022 //
GLOBENEWSWIRE
NorthStar Medical Radioisotopes Announces Supply Agreement with Aktis Oncology
23 Aug 2022 //
BUSINESSWIRE
NorthStar Medical Announces Promotion of Frank Scholz to President and COO
20 Jun 2022 //
BUSINESSWIRE
NorthStar Medical Radioisotopes, Curie Announce Priority Access Supply Agreement
07 Jun 2022 //
BUSINESSWIRE
NorthStar Medical Radioisotopes Provides Progress and Upcoming Milestones
29 Mar 2022 //
BUSINESSWIRE
NorthStar Medical Radioisotopes and Convergent Tx Announce Supply Agreement
09 Mar 2022 //
BUSINESSWIRE
NorthStar Medical Radioisotopes to Participate in Upcoming Oppenheimer Event
08 Mar 2022 //
BUSINESSWIRE
NorthStar and IBA Sign Contract for Rhodotron Electron Beam Accelerator
18 Nov 2021 //
BUSINESSWIRE
NorthStar Radioisotopes to Present at H.C. Wainwright Investment Conference
08 Sep 2021 //
BUSINESSWIRE
NorthStar Medical Radioisotopes and POINT Biopharma Announce Supply Agreement
08 Sep 2021 //
BUSINESSWIRE
NorthStar Radioisotopes Awarded $37 Million in Cooperative Agreement Funds
30 Aug 2021 //
BUSINESSWIRE
NorthStar Medical Radioisotopes and GE Healthcare Sign Exclusive Agreement
04 Aug 2021 //
BUSINESSWIRE
NorthStar Medical Technologies Announces Appointment of Frank Scholz
21 Jun 2021 //
BUSINESSWIRE
NorthStar Medical Radioisotopes Enters U.S. Supply Agreement Commercial Supply
25 May 2021 //
BUSINESSWIRE
Monopar & NorthStar Announce Selection of uPRIT Candidate for Potential
10 Dec 2020 //
GLOBENEWSWIRE
NorthStar Medical Technologies, LLC Announces Promotion of CFO Paul Estrem
05 Oct 2020 //
BUSINESSWIRE
Monopar and NorthStar Partner with Aragen for Testing of Novel Therapeutic
19 Aug 2020 //
GLOBENEWSWIRE
Monopar & NorthStar Announce Filing of Provisional Patent Protecting
30 Jun 2020 //
GLOBENEWSWIRE
Monopar and NorthStar Join Forces to Develop Radio-Immuno-Therapeutics (RITs)
16 Jun 2020 //
GLOBENEWSWIRE
